The value of histologic subtyping on outcomes of clear cell and papillary renal cell carcinomas: a meta-analysis (Q46127571)

19 December 2017

meta-analysis

0 references

title

The value of histologic subtyping on outcomes of clear cell and papillary renal cell carcinomas: a meta-analysis (English)

1 reference

19 December 2017

papillary renal cell carcinomas

main subject

1 reference

Ju-Han Lee

1

1 reference

19 December 2017

Jung-Woo Choi

series ordinal

2

1 reference

19 December 2017

Young-Sik Kim

series ordinal

3

1 reference

19 December 2017

language of work or name

English

0 references

publication date

28 March 2010

1 reference

19 December 2017

published in

Urology

1 reference

19 December 2017

volume

76

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

889-894

1 reference

19 December 2017

The Heidelberg classification of renal cell tumours.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Prognostic significance of the Heidelberg classification of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Papillary renal cell carcinoma: clinicopathological characteristics and evaluation of prognosis in 42 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Pathobiology and prognosis of chromophobe renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Incidence and long-term prognosis of papillary renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Prognostic factors in a prospective series of papillary renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Meta-analysis: formulating, evaluating, combining, and reporting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Invasion of renal sinus fat is not an independent predictor of survival in pT3a renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Impact of body mass index on survival of patients with surgically treated renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Renal cell carcinoma in South Korea: a multicenter study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Impact of clinicopathological parameters in patients treated for renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Papillary renal cell carcinoma: a clinicopathological study of 35 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Contribution of grade, vascular invasion and age to outcome in clinically localized renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Proliferative activity, angiogenesis and nuclear morphometry in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Novel agents for renal cell carcinoma require novel selection paradigms to optimise first-line therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

Targeted therapy for metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.01.039

10.1016/J.UROLOGY.2010.01.039

7 January 2021

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

20350752

1 reference

19 December 2017